Poland· PL-100303884
KETREL XR
A quetiapine product containing quetiapinum, registered in Poland by Celon Pharma S.A.. The same ATC class is registered in 18 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Quetiapine is registered in 18 of 19 countries.
Countries holding a registration under ATC N05AH04 (quetiapine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 11 of them publish a price we can compare per daily dose
Quetiapine · ATC N05AH04
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of quetiapine costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), the median price runs from $0.19 in United States to $3.93 in Switzerland — a ×20 gap.
- 5 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Quetiapine · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- CH Switzerland$3.93
- ES Spain$2.46
- IT Italy$2.42
- FR France$0.90
- US United States$0.19 (acquisition cost)
The record
At a glance
URPL (Poland)- Active substance
- Quetiapinum
- Manufacturer
- Celon Pharma S.A.
- Country
- Poland (PL)
- ATC code
- N05AH04
- ATC class
- Quetiapine
- Defined daily dose
- 0.4 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 9
- gtin05909991086121
- gtin05909991086138
- gtin05909991086060
- gtin05909991086077
- gtin05909991086084
- gtin05909991086152
- gtin05909991086091
- gtin05909991086107
- gtin05909991086145
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
559 interactions on record for quetiapine.
Graded by severity as the source publishes them — 61 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Quetiapine · interactions on record
559 records
- 61 severe
- 281 moderate
- 7 minor
- 132 info
Most severe, free to view
- PapaverineA03AD01severe
- MetoclopramideA03FA01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
78 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Quetiapine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainATROLAK PROLONG 50 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFGAccord Healthcare S.L.U.
- United KingdomAtrolak XL 50mg tabletsAccord-UK Ltd
- FranceQUETIAPINE ACCORD LP 50 mg, comprimé à libération prolongéeACCORD HEALTHCARE FRANCE
- BelgiumQuetiapin Retard Sandoz 50 mgSandoz
- FinlandBiquetanSTADA Arzneimittel AG
- CzechiaKVENTIAX PROLONGKrka, d.d., Novo mesto, Novo mesto
- CanadaACH-QUETIAPINE FUMARATE XRACCORD HEALTHCARE INC
- NetherlandsQuetiapine Accord 50 mg tabletten met verlengde afgifteAccord Healthcare B.V.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Quetialan, Quetialan 4 Tage Startpackung
- Belgium · Ketyalix, Quetiapin Retard Sandoz
- Bulgaria · Centroqueen, Бревенокс
- Cyprus · Aquetia, Ketipine
- Czechia · Derin, Derin Prolong
- Germany · Aquetia, Desiquet
- Denmark · Antoreq, Biquetan
- Estonia · Ketipinor, Kventiax
- Spain · Atrolak Prolong, Ketyalix
- Finland · Biquetan, Ketipinor
- France · Lp, Queliva
- United Kingdom (Northern Ireland) · Alaquet Xl, Atrolak Xl
- Greece · Anaquetan Xr, Aquetia
- Croatia · Kventiax, Kventiax Sr
- Hungary · Ketilept, Ketilept Prolong
- Ireland · Notiabolfen Xl, Quentiax Sr
- Iceland · Quetiapin Actavis, Quetiapin Krka
- Italy · Akelya, Quentiax
- Lithuania · Hedonin, Ketipinor
- Luxembourg · Aquetia, Quetiapine Eg
- Latvia · Ketipinor, Kventiax
- Malta · Quetex, Quetex Xr 50mg
- Netherlands · Aquetia, Quetiapine
- Norway · Quetiapin Krka, Quetiapin Orion
- Portugal · Anaquetan Xr, Aquetia
- Romania · Kventiax, Kventiax Ep
- Sweden · Biquetan, Quetiapin Hexal
- Slovenia · Kvelux, Kvelux Sr
- Slovakia · Derin, Derin Prolong
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fc9981d3-de7d-46f1-8db6-e13aa811275e GET /v1/drugs/fc9981d3-de7d-46f1-8db6-e13aa811275e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki o przedłużonym uwalnianiu",
"source": "urpl",
"strength": "50 mg",
"packaging": "05909991086060 ¦ Rp ¦ 86599\n6 tabl.\n05909991086077 ¦ Rp ¦ 86600\n10 tabl.\n05909991086084 ¦ Rp ¦ 86601\n20 tabl.\n05909991086091 ¦ Rp ¦ 86602\n28 tabl.\n05909991086107 ¦ Rp ¦ 86603\n30 tabl.\n05909991086121 ¦ Rp ¦ 86604\n50 tabl.\n05909991086138 ¦ Rp ¦ 86605\n60 tabl.\n05909991086145 ¦ Rp ¦ 86606\n90 tabl.\n05909991086152 ¦ Rp ¦ 86607\n100 tabl.",
"substance": "Quetiapini fumaras 50 mg",
"common_name": "Quetiapinum",
"pl_product_id": "100303884",
"pozwolenie_nr": "21482",
"auth_procedure": "DCP",
"authorisation_validity": "2024-02-16"
}See everything about quetiapine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.